No label defined (Q32171)

From lgbtDB
Revision as of 23:19, 14 November 2024 by Superraptor (talk | contribs) (‎Created a new Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
No description defined
  • Metabolic and cardiovascular risks of hormone treatment for transgender individuals.
Language Label Description Also known as
English
No label defined
No description defined
  • Metabolic and cardiovascular risks of hormone treatment for transgender individuals.

Statements

title
Metabolic and cardiovascular risks of hormone treatment for transgender individuals. (English)
1 reference
stated in
PubMed
abstract
Identifying metabolic and cardiovascular risks of gender-affirming hormone therapy (GAHT) is challenging due to other confounding variables that affect patient outcomes and the diversity of treatment regimes. (English)
series ordinal
1
copyright statement
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Q32168
Anastasia Dimakopoulou
Q32169
Q32170
1 reference
stated in
PubMed
Masculinising hormone therapy produces atherogenic lipid profiles, while effects on other metabolic parameters are not consistent. (English)
series ordinal
2
copyright statement
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Q32168
Anastasia Dimakopoulou
Q32169
Q32170
1 reference
stated in
PubMed
There is insufficient evidence to conclude if cardiovascular disease risk among transmen is increased. (English)
series ordinal
3
copyright statement
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Q32168
Anastasia Dimakopoulou
Q32169
Q32170
1 reference
stated in
PubMed
The effects of feminising hormone therapy on metabolic parameters do not demonstrate a consistent pattern in the available literature. (English)
series ordinal
4
copyright statement
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Q32168
Anastasia Dimakopoulou
Q32169
Q32170
1 reference
stated in
PubMed
However, the risk of venous thromboembolism is greater in transwomen than in cis-gender men and women with a possible increase in cardiovascular disease risk. (English)
series ordinal
5
copyright statement
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Q32168
Anastasia Dimakopoulou
Q32169
Q32170
1 reference
stated in
PubMed
It is recommended to discuss the potential effects of GAHT on cardiovascular health and encourage patients seeking GAHT to adopt a healthy lifestyle. (English)
series ordinal
6
copyright statement
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Q32168
Anastasia Dimakopoulou
Q32169
Q32170
1 reference
stated in
PubMed
Performing baseline and periodic assessments of cardiovascular risk factors would enable early identification and interventions. (English)
series ordinal
7
copyright statement
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Q32168
Anastasia Dimakopoulou
Q32169
Q32170
1 reference
stated in
PubMed
In high-risk individuals, the cardiovascular effects of hormonal regimes might impact the treatment decision. (English)
series ordinal
8
copyright statement
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Q32168
Anastasia Dimakopoulou
Q32169
Q32170
1 reference
stated in
PubMed
date published
September 2024
1 reference
stated in
PubMed
date issued
September 2024
1 reference
stated in
PubMed
volume
38
1 reference
stated in
PubMed
issue
5
1 reference
stated in
PubMed
page(s)
101907
1 reference
stated in
PubMed
page start
101907
1 reference
stated in
PubMed
publisher item identifier
S1521-690X(24)00061-7
1 reference
stated in
PubMed
conflict-of-interest statement
Declaration of Competing Interest The authors have nothing to declare. (English)
series ordinal
1
1 reference
stated in
PubMed
 
Retrieved from "https://lgbtdb.wikibase.cloud/w/index.php?title=Item:Q32171&oldid=190101"